201 related articles for article (PubMed ID: 25750072)
21. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
[TBL] [Abstract][Full Text] [Related]
22. [Studies on the determinants and changes related to the natural CD4(+) T cell counts among antiretroviral treatment-naive HIV/AIDS patients in Dehong prefecture, Yunnan province].
Ye RH; Duan S; Xiang LF; Yang YC; Yang ZJ; Han WX; Cao DD; Yang JH; Li WM; Yang J; Wang JB; Gao J; Gong YR; Yang SJ; Zhu P; He N
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):882-7. PubMed ID: 22340875
[TBL] [Abstract][Full Text] [Related]
23. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
24. Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa.
Lowick S; Sawry S; Meyers T
Psychol Health Med; 2012; 17(5):599-610. PubMed ID: 22313239
[TBL] [Abstract][Full Text] [Related]
25. No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts.
Wright EJ; Grund B; Robertson KR; Cysique L; Brew BJ; Collins GL; Poehlman-Roediger M; Vjecha MJ; Penalva de Oliveira AC; Standridge B; Carey C; Avihingsanon A; Florence E; Lundgren JD; Arenas-Pinto A; Mueller NJ; Winston A; Nsubuga MS; Lal L; Price RW;
AIDS; 2018 May; 32(8):985-997. PubMed ID: 29424786
[TBL] [Abstract][Full Text] [Related]
26. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children.
Jeremy RJ; Kim S; Nozyce M; Nachman S; McIntosh K; Pelton SI; Yogev R; Wiznia A; Johnson GM; Krogstad P; Stanley K;
Pediatrics; 2005 Feb; 115(2):380-7. PubMed ID: 15687448
[TBL] [Abstract][Full Text] [Related]
27. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
[TBL] [Abstract][Full Text] [Related]
28. Can antiretroviral therapy prevent HIV-associated cognitive disorders?
Winston A; Vera JH
Curr Opin HIV AIDS; 2014 Jan; 9(1):11-6. PubMed ID: 24275675
[TBL] [Abstract][Full Text] [Related]
29. Current scenario of opportunistic and co-infections in HIV-infected individuals at a tertiary care hospital in Mumbai, India.
Chavan VR; Chaudhary V; Ahir P; Mehta R; Mavani PS; Kerkar C; Pramanik JM
Indian J Med Microbiol; 2015; 33(1):78-83. PubMed ID: 25560006
[TBL] [Abstract][Full Text] [Related]
30. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
[TBL] [Abstract][Full Text] [Related]
31. Nevirapine versus efavirenz based antiretroviral treatment in naive Indian patients: comparison of effectiveness in clinical cohort.
Patel AK; Pujari S; Patel K; Patel J; Shah N; Patel B; Gupte N
J Assoc Physicians India; 2006 Dec; 54():915-8. PubMed ID: 17334006
[TBL] [Abstract][Full Text] [Related]
32. Factors related to HIV-associated neurocognitive impairment differ with age.
Fogel GB; Lamers SL; Levine AJ; Valdes-Sueiras M; McGrath MS; Shapshak P; Singer EJ
J Neurovirol; 2015 Feb; 21(1):56-65. PubMed ID: 25404233
[TBL] [Abstract][Full Text] [Related]
33. Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India.
Rajasekaran S; Jeyaseelan L; Raja K; Vijila S; Krithigaipriya KA; Kuralmozhi R
J Postgrad Med; 2009; 55(4):261-6. PubMed ID: 20083872
[TBL] [Abstract][Full Text] [Related]
34. An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China.
Zhang Y; Qiao L; Ding W; Wei F; Zhao Q; Wang X; Shi Y; Li N; Smith D; Chen D
J Neurovirol; 2012 Apr; 18(2):120-6. PubMed ID: 22411002
[TBL] [Abstract][Full Text] [Related]
35. Neurological manifestation with special reference to HIV-associated neurocognitive disorder (HAND) among people on anti-retroviral treatment in India.
Shaik RA; Holyachi S; Ahmad MS; Ahmad RK; Yusuf M; Khan M; Almutairi AB; Alghuyaythat WKZ
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6999-7004. PubMed ID: 34859862
[TBL] [Abstract][Full Text] [Related]
36. Cognitive Function among HIV Infected Children in Pune.
Ghate M; Narkhede H; Rahane G; Nirmalkar A; Gaikwad N; Kadam D
Indian J Pediatr; 2015 Jun; 82(6):515-8. PubMed ID: 25432090
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.
Morgan EE; Woods SP; Letendre SL; Franklin DR; Bloss C; Goate A; Heaton RK; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Ellis RJ; Abramson I; Gamst A; Fennema-Notestine C; Smith DM; Grant I; Vaida F; Clifford DB;
J Neurovirol; 2013 Apr; 19(2):150-6. PubMed ID: 23408335
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
[TBL] [Abstract][Full Text] [Related]
39. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
Wolbers M; Bucher HC; Furrer H; Rickenbach M; Cavassini M; Weber R; Schmid P; Bernasconi E; Hirschel B; Battegay M;
HIV Med; 2008 Jul; 9(6):397-405. PubMed ID: 18410354
[TBL] [Abstract][Full Text] [Related]
40. Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect.
Grund B; Wright EJ; Brew BJ; Price RW; Roediger MP; Bain MP; Hoy JF; Shlay JC; Vjecha MJ; Robertson KR;
J Neurovirol; 2013 Aug; 19(4):383-92. PubMed ID: 23943468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
